Cittadine Andrew 4
4 · Monopar Therapeutics · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Monopar (MNPR) COO Andrew Cittadine Receives RSU Shares
What Happened
Andrew Cittadine, Chief Operating Officer of Monopar Therapeutics (MNPR), had 5,254 restricted stock units (RSUs vest) on June 30, 2026. Those RSUs were converted into 5,254 common shares; the company withheld 2,309 of those shares to cover applicable withholding taxes, valued at $92.59 per share for a total tax withholding of $213,790. Net newly issued shares to Cittadine = 2,945 (5,254 vested − 2,309 withheld).
Key Details
- Transaction date: June 30, 2026; filing date: July 2, 2026.
- Vesting/conversion (derivative exercise, code M): 5,254 RSUs converted into 5,254 common shares.
- Tax withholding (code F): 2,309 shares withheld at $92.59/share, total $213,790.
- Net shares received: 2,945 shares after withholding.
- Footnotes: These shares came from scheduled RSU grants (grants dated Feb 1, 2023; Mar 4, 2025; Dec 2, 2025) that vest on a multi‑quarter schedule. Disposals labeled as derivative surrender indicate RSUs were exchanged for common stock upon vesting.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- No 10b5-1 plan or late‑filing indication shown in the provided data.
Context
This was a routine RSU vesting and settlement, not an open‑market purchase or sale by the insider. The withholding of shares to cover taxes is common for RSU settlements and is recorded as a disposition (code F). The dual reporting of acquired shares and the surrendered derivative reflects issuance of stock upon vesting and cancellation of the underlying RSUs.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-30+5,254→ 57,923 total - Tax Payment
Common Stock
[F2]2026-06-30$92.59/sh−2,309$213,790→ 55,614 total - Exercise/Conversion
Restricted Stock Unit
[F1][F3][F4][F5]2026-06-30−5,254→ 39,499 total→ Common Stock (5,254 underlying)
Footnotes (5)
- [F1]Represents shares acquired on vesting and settlement of restricted stock units.
- [F2]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- [F3]On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F4]On March 4, 2025, the reporting person was granted 40,581 restricted stock units, vesting 6/48ths (5,073 shares) on June 30, 2025, and 3/48ths (2,536 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F5]On December 2, 2025, the reporting person was granted 13,919 restricted stock units, vesting 6/48ths (1,740) on June 30, 2026, and 3/48ths (870 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.